EFIB2008

click here to download a printable version of the programme

Workshops - Monday, 15 September 2008

Workshop 1: Fundamentals of Industrial Biotechnology

Workshop 2: Industrial enzymes and their applications

15:00 – 17:30	Workshop content
	• Overview of recent advances in industrial enzymes and their applications
	Steen Skjold-Jørgensen, Vice President R&D, NOVOZYMES, US
	• The role of enzymes as drivers for climate change and sustainability • Exploring the importance of LCAs and how to apply these correctly to enzyme applications - Examples of enzyme benefits for CO2 emission in a range of applications - Focus on the biofuels cases
	Per H Nielsen, PhD, Manager, Sustainability Development, NOVOZYMES A/S, Denmark
	• Recent advances in enzymes and their applications in food and animal feed
	Rob Beudeker, Director, Ingredient Development Unit, DSM FOOD SPECIALTIES, Netherlands
	• Miniaturising the laboratory into droplets: enzyme engineering and screening in the future
	Prof Andrew Griffith, Supramolecular Science and Engineering Institute (ISIS), Louis Pasteur Strasbourg University, France
	Your workshop chair:
	Steen Skjold-Jørgensen, Vice President R&D, NOVOZYMES, US

Forum day 1 - Tuesday, 16 September 2008

Morning

Plenary session: Industrial biotechnology market developments

08:00	Registration and refreshments
09:00	Opening remarks from the chair
09:10	Keynote address: the emerging carbohydrate economy
	• Exploring industrial biotechnology and the many uses of plant matter • What rules can guide us to achieve social and economic as well as energy and environmental goals?
	Dr David Morris, Director of THE NEW RULES PROJECT and the INSTITUTE FOR LOCAL SELF-RELIANCE, US
09:40	Industry key note address: perspectives and future outlook for a biobased economy – creating sustainable industrial activities
	• Incorporating sustainability in all aspects of society • Overview of market sectors that already benefit and those that can benefit from industrial biotechnology • Developing viable bio-based products that can compete on price and performance • Understanding shortcomings, challenges and opportunities for Europe
	Nick Fanandakis, Group Vice President, Applied Biosciences, DUPONT, US
10:10	Industrial biotechnology market analysis: turning potential into profits
	• Up-to-date date data and projections for adoption of industrial biotechnology within biofuels and chemicals industries • Future predictions • Feedstock usage • Overcoming challenges and industry constraints, especially environment and sustainability issues
	Nicolas Denis, Partner, MCKINSEY & COMPANY, Belgium
10:40	Morning refreshments
11:10	Achieving a biobased knowledge economy: European roadmap to KBBE
	• What is the KBBE (knowledge-based bio-economy)? • Exploring the socio-economic importance of the KBBE • Understanding EU strategy on biotechnology • Framework programme 7 • Addressing food, agriculture, biotechnology and the KBBE • Forecasted R&D activities for 2009 within KBBE • Examining the European Commission and stakeholder dialogue: ETPs (European Technology Platforms), industrial associations and SMEs • Analysing the Lead Market Initiative for bio-based products
	Dr Alfredo Aguilar, Head of Unit Biotechnology Directorate Food, Agriculture and Biotechnology Research Directorate General, EUROPEAN COMMISSION
11:40	Exploring the role of The Lead Market Initiative on biobased product development in Europe
	• Evaluating the potential of removing innovation barriers, setting standards, improving procurement and providing access to finance • Analysing policy recommendations • Ensuring successful outcomes of pilot programmes
	Prof Catia Bastioli, CEO, NOVAMONT, Italy
12:10	US perspective: incentivising renewable and biobased products
	• Lessons learnt from initiatives within biofuels and bioplastics • Accelerating breakthroughs and research collaboration across the industry • A review of the ethanol market boom
	Brent Erickson, Executive Vice President, Industrial and Environmental Section, BIOTECHNOLOGY INDUSTRY ORGANIZATION, US
12:40	Asian perspective: evaluating current and future potential and market conditions across the Asia Pacific region for white biotechnology
	• Lessons learnt from China and other growing regions • Case studies of key providers have opened research and production facilities • Challenges and opportunities • Future outlook
	Dr Ling Hua, Director, China Research Center, GENENCOR, China
13:10	Lunch will be served for all speakers and delegates

Afternoon parallel session 1

Is industrial biotechnology leading to sustainable bio-based products?

14:20	Introduction from the chair
	Ian Hudson, President EMEA, DUPONT DE NEMOURS INTERNATIONAL, Switzerland
14:30	What is the ′value proposition’ for switching to a bio-renewable carbon feedstock base?
	• How does incorporating bio content into a product reduce carbon footprint and move to a zero carbon footprint? • How do you define a ′bio product’ and how do you identify and measure bio content? • How to compute and report on carbon and environmental footprint of bioplastics and products using LCA tools • Understanding LCA and the ′use’ and ′misuse’ of LCA with bio plastics and products • Understanding biodegradability and end of life options for bioplastics and bioproducts?
	Dr Ramani Narayan, University Distinguished Professor, Department of Chemical Engineering & Materials Science, MICHIGAN STATE UNIVERSITY, US
14:55	Investigating tools for measuring the environmental impact of biobased products: LCA’s
	• Applying Life Cycle Assessment analysis (LCA’s) for end applications • Understanding how green your product really is • Incorporating the entire life cycle of the product (feedstock, refining, process, energy, supply chain, recyclability, etc) • Interpretation and reliability
	Gary Parker, Sustainability Director, CIBA SPECIALTY CHEMICALS, UK
15:20	Sustainability of biobased products: the NGO perspective
	• What is on the agenda? • Exploring opportunities and challenges • Assessing the long term sustainability of biobased products • Future trends
	Dr Stephan Singer, Head of EUROPEAN CLIMATE AND ENERGY POLICY UNIT WWF, Belgium
15:45	Afternoon refreshments
16:05	Sustainability and success of biobased products and processes
	• Building on a Tripple helix strategy to ensure success • Exploring the broad spectrum of products and processes within sustainability through biological solutions: waste to value through biomass conversion • Identifying the inherent technological advantage of industrial biotechnology • Understanding
	Prof Lene Lange, Department Head, Department of Biology, UNIVERSITY OF OPENHAGEN, Denmark
16:30	Understanding the role of sustainable production and consumption and the Sustainable Industrial Policy action plan
	• Outline of the action plan • Main elements of the proposed approach to product policy • An industrial policy approach to environmental industries • Action at a global level
	Dino Pinelli, Directorate General Enterprise and Industry, EUROPEAN COMMISSION
16:55	Panel discussion: innovation and commercialisation – what will make Europe embrace white biotechnology?
	• Assessing the level of government involvement and support across Europe • Evaluating the need for industry incentives and economic drivers • In search for the enabling part of biotechnology in Europe
	Panel chair: Prof Lene Lange, Department Head, Department of Biology, UNIVERSITY OF COPENHAGEN, Denmark Panel participants from this session
17:30	Closing remarks from the chair
17:45	Drinks reception
	All speakers and delegates are invited to a relaxed and informal drinks reception, providing an opportunity to network and discuss the day’s proceedings

Afternoon parallel session 2

Biorefineries: innovation and new technology

14:20	Introduction from the chair
	Jack Huttner, Vice President, Biorefinery Business Development, GENENCOR, US
14:30	Exploiting renewable feedstocks: competing with or sharing the food chain?
	• How to avoid competition with food resources • Meeting shortages and finding alternatives
	Dietrich Klein, Chairman of Working Group Biotechnology/Bioenergy, COPA COGECA, Germany
14:55	Biorefineries: combined use of biomass as a source of energy, fuels and materials
	• Biorefinery: definition of a production system • Exploring biorefinery concepts: different approaches and examples • Conclusion and future outlook
	Dr George Deerberg, Director of Science, UMSICHT FRAUNHOFER, Germany
15:20	Global overview of biorefining initiatives and biofuels applications
	• Assessing global impact of biofuels • Market overview, drivers and outlook • Political agenda and media • Future developments
	Poul Ruben Andersen, Marketing Director, NOVOZYMES, Denmark
15:45	Afternoon refreshments
16:05	Building the biorefinery business in the future: case study of a working integrated forest biorefinery
	• Creating partnerships for successful development of the forest biorefinery • How innovative partnerships and research clusters are helping to drive innovation and achieving commercial success • Lessons learnt and challenges overcome • One step closer to a second generation biorefinery
	Peter Blomqvist, CEO, PROCESSUM BIOREFINERY INITIATIVE, Sweden
16:30	Fermentation: a versatile technology utilising renewable resources
	• Chemical based on fermentation • Drivers for choosing fermentation versus chemical processes • Overcoming the challenge of the availability of cheaper raw materials prices for fermentation • Achieving competitive prices compared to conventional chemical products • Challenges that are unique to fermentation
	Dr Oskar Zelder, Fermentation Products Specialty Chemicals Research, BASF, Germany
16:55	Panel discussion: biorefining and biofuels outlook
	• Market drivers and outlook • Impact of biofuels • Food chain considerations • Encouraging innovation and development • Future outlook
	Panel chair:Jack Huttner, Vice President, Biorefinery Business Development, GENENCOR, US Panel participants from this session
17:30	Closing remarks from the chair
17:45	Drinks reception
	All speakers and delegates are invited to a relaxed and informal drinks reception, providing an opportunity to network and discuss the day’s proceedings

Forum day 2 - Wednesday, 17 September2008

Morning

Plenary session: The future of a bio-based economy: end-user perspective

08:00	Registration and refreshments
08:30	Achieving the biobased economy: where are we? Opening remarks from the chair
	Iain Gillespie, Head of Biotechnology Division, OECD, France
08:40	Advances and future potential of biofuels: a truly green alternative?
	• Latest advances in biofuels and uses • Attitudes, national policies and uptake • Assessing opportunities and challenges • Exploring the potential of a second generation of biofuels
	Harri Turpeinen, Vice President Corporate Stakholder Relations, NESTE OIL CORPORATION, Finland
09:10	Automotive perspective: biomaterials in the automotive sector
	• Recent advances in the use of biomaterials for automotive applications • Latest developments in biofuels • Uses of natural fibre composites • Opportunities and obstacles for biomaterials
	Otmar Hauck, Plastic Parts Unit, VOLKSWAGEN, Germany
09:40	Consumer goods perspective: utilising biotechnology to improve consumer products – opportunities and challenges
	• Enhancing existing products through industrial biotechnology • Addressing advantages and shortcomings • Functional product properties
	Neil Parry, Science Area Leader - Biotechnology, UNILEVER RESEARCH, UK
10:10	Morning refreshments
10:50	Utilising biotechnology to reach sustainable production for chemicals, materials and pharmaceuticals
	• Evaluating current technologies vs white biotechnology alternatives • Cost benefit analysis • Future markets and applications
	Stephan Tanda, Board Member, DSM, Netherlands
11:20	Industrial biotechnology and applications in the personal care industry
	• Growth in industrial biotechnology capabilities and applications • Exploring application and cost effectiveness • Identifying the growth in the personal care/cosmetics marketplace • Evaluating industrial biotechnology applications today and their future potential in this market
	Dr Surinder P Chahal, Technical Director – Enterprise Technologies and Suncare and Biopolymers, CRODA EUROPE, UK
11:50	Industrial biotechnology in the pharmaceutical industry
	• Where are the synergies between industrial and pharmaceutical biotechnology? • What are the production options today and tomorrow? • Small and large molecule pharmaceutical production using biosynthesis and biotransformation in contained systems • A specific interesting example: new biomaterials for pharma applications • Burning issues and real life business drivers?
	Hans-Peter Meyer, VP Technology Evaluation, LONZA, Switzerland
12:20	Panel discussion: future of biobased materials
	• Differing product and industry specific requirements • The sustainability concept and what it means for end use applications • Future predictions on biobased products capabilities in 10 years time
	Panel participants: Stefano Facco, New Business Development Manager, Novamont, Italy. Volkert Claassen, Vice President White Biotechnology, DSM, Netherlands, and Vincent de Jung, PURAC, Netherlands. Plus speakers from this session
13:10	Lunch will be served for all speakers and delegates

Afternoon parallel session 1

From knowledge to products: overcoming barriers to commercialisation

14:15	Introduction from the chair
	Anindya Mukherjee, Executive VP Industrial Biotechnology, DIREVO BIOTECH, Germany
14:25	Increasing the public interaction on industrial biotechnology: educating the consumer and the biotechnologist
	• Analysing consumer awareness of industrial biotechnology • Meeting consumer concerns • Capitalising on labelling • How to distinguish your product from others?
	Dr Patricia Osseweijer, Managing Director & Programme Leader Genomics and Society, KLUYVER CENTRE, and Assistant Professor, Biotechnology and Society Department of Biotechnology, DELFT UNIVERSITY OF TECHNOLOGY, Netherlands
14:45	Market entry: assessing the current investment climate in Europe
	• Understanding the current investment models available today for SMEs/ start-ups • How to raise venture capital for industrial biotechnology • Limited interest of the financial community due to lack of experience and success stories • What could the chemical industry learn from the pharma industry where venture capital is funding SMEs
	Dr Manfred Kircher, President, CLIB2021 (EVONIK INDUSTRIES), Germany
15:05	The positioning of start-ups in the white biotech domain
	• Exploring the small company integrator role • Analysing the European start-up marketplace • Identifying challenges and how these will be overcome • Assessing future growth potential
	Marc Delcourt, Director R&D, BIOMETHODES, France
15:25	IB investment: a new sector, a new model
	• IB is emerging as a vital new industry force and covers a broad range of applications and industries • An investment model for IB must address three distinct phases: research, development scale-up and industrial production • Addressing the different drivers at each phase: IP creation, process development and economic full-scale production • Financing the different phased will need appropriate funding sources adapted to the phase • The adaptable value chain
	Martin Austin, Partner, MARRAM ADVISORS, Switzerland
15:45	Afternoon refreshments
16:05	Case study: putting public-private partnership into practice – analysing first results
	• Lessons learnt from private partnerships in France: BioHub • New concepts and new developments • Identifying first results
	Christophe Rupp-Dahlem, Program Director, ROQUETTE, France
16:25	Creating novel bioprocesses by collaborations between academia and industry
	• Examining the modus operandi of Centre of Excellence in Biocatalysis (CoEBio3) at University of Manchester • Understanding benefits to Industrial Consortium of being members • Analysing the funding model: core research programme • Case studies of successful academia/industry research projects • Opportunities for IP development/spin-outs
	Prof Nicholas J Turner, Director of Centre of Excellence in Biocatalysis, CoEBio3, MANCHESTER INTERDISCIPLINARY BIOCENTRE, UK
16:45	Panel discussion: collaboration across the value chain – turning innovation into commercial business
	• Analysing the industry need for collaboration partners to speed up processes and commercialisation • Understanding the importance of finding the right collaboration partner, the need for integrators and potential for SMEs to act as integrators • Lessons learnt from the pharma industry on successful collaboration involving SMEs and start–ups • Lack of interest from investors in Europe due to weak government incentives?
	Panel chair: Anindya Mukherjee, Executive VP Industrial Biotechnology, DIREVO BIOTECH, Germany Panel participants: Dr Manfred Kircher, President, CLIB2021 (EVONIK INDUSTRIES), Germany; Dr Bernhard Mohr, Investment Manager, BASF VENTURE CAPITAl, Germany; Dr Simon Best, Chair, INTERNATIONAL CROPS RESEARCH INSTITUTE, UK; Steen Andersen, CEO, FLUXOME SCIENCES, Denmark; Mr Arno van der Ven, Global Director of the Chemical & Pharma Division, PURAC;
17:30	Closing remarks from the chair and close of conference

Afternoon parallel session 2

Future outlook: new developments, novel products and research advances

14:15	Introduction from the chair
	Prof Wim Soetaert, Faculty of Bioscience Engineering, GHENT UNIVERSITY, Belgium
14:25	Producing sustainable chemicals and polymers: new product development in the future
	• The role of SMEs and larger companies in driving research forward • Exploring the challenge of producing biobased chemicals and polymers in bulk quantities • Overcoming shortcomings of biopolymers: is the performance there yet? • Biosourcing of intermediates to existing polymers and materials
	Philippe Guinot, Business Development, METABOLIC EXPLORER, France
14:45	Embracing green biotechnology: the importance of green biotechnology in relation to supplying white biotech input
	• Exploring the challenges of green biotechnology and food supply issues • How can Europe supply input for white biotechnology? • Comparing output in the US and Europe • Future outlook
	Dr Bernward Garthoff, CTO, BAYER CROPSCIENCE, Germany
15:05	Biosynthesis of innovative tailormade biopolymers
	• Synthetic genes encoding novel structural polypeptides • Microbial production of self-assembling structural polypeptides • Enzymatic synthesis of glycosaminoglycans (e.g. hyaluronic acid and heparin) • Medical and pharmaceutical applications
	Prof Gerrit Eggink, Professor of Industrial Biotechnology, Agrotechnology and Food Sciences Group, WAGENINGEN UR, Netherlands
15:25	Advances in enzymes: tools for natural food processing
	• Characteristics of food enzymes • Impact of enzymes on processability • Food structure engineering with enzymes • Tailoring food flavour with enzymes • Natural ingredients by enzyme-aided valorisation of plant by-products • Latest technology developments and opportunities
	Johanna Buchert, Research Professor, VTT TECHNICAL RESEARCH CENTRE, Finland
15:45	Afternoon refreshments
16:05	′Blue sea science’: applications of blue biotechnology
	• Overview of blue biotechnology: unique environment and unique biota • Applications of blue biotechnology in different industry sectors • Challenges posed by commercialising discoveries from marine and aquatic environments • Case studies from research at Aberdeen University • Increasing the impact of blue biotechnology via national and international policy initiatives
	Prof Marcel Jaspars, Marine Biodiscovery Centre, Department of Chemistry, UNIVERSITY OF ABERDEEN, UK
16:25	Testing chemical intermediates: integrated research from feasibility study to industrial demonstration plant
	• Phasing a research project in white biotechnology in a cluster project, exploring: • Achieving an industrial demonstration plant to finalise on continuous investment operation, mass and energy balance, VOC and waste stream values, and to test the chemical intermediate in industrial facilities
	Yvon Le Hénaff, General Manager, ARD, France
16:45	Panel discussion: driving research forward
	• Managing research projects most effectively • R & D vs commercial interests • Future prediction on research and development processes • Future outlook on where industrial biotechnology is in 10 years time
	Panel chair: Prof Wim Soetaert, Faculty of Bioscience Engineering, GHENT UNIVERSITY, Belgium Panel participants from this session
17:30	Closing remarks from the chair and close of conference

about the forum

programme

sponshorship & exhibitios

media & associations

venue details

contacts & bookings